Dr Andrew Mallon founded Calista Therapeutics in 2012 based upon the discovery and development of a technology platform of therapeutics that modulate the cellular transport, location and activation of regulatory proteins. Dr Mallon is a biotech entrepreneur, specializing in the identification and creation of early stage value in promising therapeutics in diseases that have high unmet clinical need and de-risked development pathways.
Previously Dr Mallon founded Ardane Therapeutics, Inc. (USA), and Carlton Pharmaceutics (UK). Dr Mallon is an inventor on several patents based upon his discoveries in addition to several publications. Dr Mallon has a Ph.D. from the University of Glasgow, taught and undertook research at Brown University and is a registered pharmacist. Dr Mallon has served as an expert scientific reviewer for both the NIH and NSF grant committees focused upon drug development.
Intro to the Rhode Island Startup Community
Get the the inside scoop on key events/meetups to attend, people, companies, VCs, blogs, incubators, programs, hot issues, and more.